CELH
Celsius Holdings, Inc.
CELH has the edge over IPAR overall, supported by stronger modeled upside and stronger fundamentals.
IPAR
Inter Parfums, Inc.
IPAR trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
IPAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Unavailable |
IPAR's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over IPAR in the historical PE scenario, which offers more potential upside but is not a forecast.
IPAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $119 | -9.1% |
| Current | 25x | $131 | — |
| Fair | 28x | $151 | +15% |
| Forward | 28x | $131 | — |
| Expensive | 37x | $196 | +50% |
Historical ranges are pointers, not guarantees.
IPAR's PE is in its cheap range at 25x. On analysts' estimates for next year's earnings, today's price would be 28x, in its fair range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over IPAR on the outlook, with more favorable valuation and earnings expectations.
IPAR Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect IPAR's profitability to weaken, with its earnings and revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
IPAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.72 | -11% |
| Q3 2026 | $5.31 | +3.3% |
| Q2 2026 | $5.23 | +4.2% |
| Q1 2026 | $5.27 | +1.9% |
| Q4 2025 | $5.24 | +2.3% |
| Q3 2025 | $5.14 | +10% |
| Q2 2025 | $5.02 | +14% |
| Q1 2025 | $5.17 | +19% |
| Q4 2024 | $5.12 | +7.8% |
IPAR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over IPAR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
IPAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $429.5M | 0% |
| Q2 2026 | $341M | +2.1% |
| Q1 2026 | $344.9M | +1.8% |
| Q4 2025 | $386.2M | +6.8% |
| Q3 2025 | $429.6M | +1.2% |
| Q2 2025 | $333.9M | -2.4% |
| Q1 2025 | $338.8M | +4.6% |
| Q4 2024 | $361.5M | +10% |
IPAR's revenue grew through 2024 and has held roughly level since: $430M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +2.2 points |
| Q2 2026 | 14% | -3.4 points |
| Q1 2026 | 22% | -0.7 points |
| Q4 2025 | 7.1% | -2.8 points |
| Q3 2025 | 25% | +0.3 points |
| Q2 2025 | 18% | -1.2 points |
| Q1 2025 | 22% | +1.2 points |
| Q4 2024 | 10% | +4.2 points |
IPAR has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
IPAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $55.2M | -4.3% |
| Q2 2026 | $44.6M | +$47.9M |
| Q1 2026 | -$1.3M | +$7.5M |
| Q4 2025 | $145M | +6.5% |
| Q3 2025 | $57.6M | -24% |
| Q2 2025 | -$3.3M | -114% |
| Q1 2025 | -$8.8M | +$44.2M |
| Q4 2024 | $136.1M | +71% |
IPAR has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over IPAR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
IPAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +13K shares |
| 1 year | -0.3% | -110K shares |
| 3 years | +1.3% | +420K shares |
IPAR has 32M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $3.9M |
| Q4 2025 | $6.4M |
| Q3 2025 | $5.4M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $4.1M |
IPAR spent $10M buying back its own shares over the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
IPAR Net Leverage
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
IPAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.0 | Neutral |
| Stochastic | 70.2 | Neutral |
IPAR's weekly RSI is 65 (neutral) and its Stochastic is 70 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
IPAR PE vs Consumer Defensive Sector
| Metric | IPAR | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 19x | 26% above |
| PE % | 26 | 18 | 8 pts above |
IPAR has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
IPAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $119.7 | 9.2% above |
| 20 week MA | $118.9 | 9.9% above |
| 50 week MA | $103.7 | 26% above |
| 100 week MA | $110.8 | 18% above |
| 200 week MA | $121.1 | 8% above |
IPAR has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
IPAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.6 | $59.4 | -18% |
| 2021 | $59.4 | $102.1 | +72% |
| 2022 | $102.1 | $98.7 | -3.4% |
| 2023 | $98.7 | $144.0 | +46% |
| 2024 | $144.0 | $131.1 | -9% |
| 2025 | $131.1 | $85.7 | -35% |
| 2026 YTD | $85.7 | $130.8 | +53% |
IPAR has the edge over CELH on returns for 2026, with the stronger performance.